EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
    2.3.3.8 | Acidosis |
8941657 |
Adenosine triphosphate citrate lyase mediates hypocitraturia in rats. |
causal interaction
ongoing research
therapeutic application
unassigned |
3
3
1
0 |
| 2.3.3.8 | Acidosis |
9844143 |
Converting enzyme inhibition causes hypocitraturia independent of acidosis or hypokalemia. |
causal interaction
therapeutic application
unassigned |
4
1
0 |
| 2.3.3.8 | Adenocarcinoma |
26221340 |
ATP citrate lyase expression is associated with advanced stage and prognosis in gastric adenocarcinoma. |
causal interaction
diagnostic usage
unassigned |
3
4
0 |
| 2.3.3.8 | Alzheimer Disease |
6133246 |
Coenzyme A-acetylating enzymes in Alzheimer's disease: possible cholinergic 'compartment' of pyruvate dehydrogenase. |
causal interaction
diagnostic usage
ongoing research
unassigned |
1
1
1
0 |
| 2.3.3.8 | Ataxia Telangiectasia |
28689661 |
Nuclear Acetyl-CoA Production by ACLY Promotes Homologous Recombination. |
therapeutic application
unassigned |
1
0 |
| 2.3.3.8 | Atherosclerosis |
26983688 |
New Era of Lipid-Lowering Drugs. |
causal interaction
therapeutic application
unassigned |
1
1
0 |
| 2.3.3.8 | Atherosclerosis |
27892461 |
Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosis. |
causal interaction
therapeutic application
unassigned |
3
4
0 |
| 2.3.3.8 | Atherosclerosis |
28153881 |
Prevention of Diet-Induced Metabolic Dysregulation, Inflammation, and Atherosclerosis in Ldlr(-/-) Mice by Treatment With the ATP-Citrate Lyase Inhibitor Bempedoic Acid. |
causal interaction
therapeutic application
unassigned |
1
4
0 |
| 2.3.3.8 | Atherosclerosis |
31499095 |
ATP-citrate lyase (ACLY) in lipid metabolism and atherosclerosis: An updated review. |
causal interaction
therapeutic application
unassigned |
2
1
0 |
| 2.3.3.8 | Atherosclerosis |
34047441 |
Targeting angiopoietin-like 3 in atherosclerosis: From bench to bedside. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
4
3
4
0 |
